Catalyst Wire Dossier Catalyst Wire Dossier

TAXUS Liberté paclitaxel-eluting stent

paclitaxel-eluting stent · Boston Scientific Corporation
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TAXUS Liberté paclitaxel-eluting stent, covering 2015-04-13 to 2015-04-13. Get the full timeline:

Most recent: Clinical Trial Update: TAXUS Libertē Post Approval Study

See pricing